Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » immunotherapy

Home › Forums › Topic Tag: immunotherapy

Topic Tag: immunotherapy

Home › Forums › Topic Tag: immunotherapy

Viewing 5 topics - 1 through 5 (of 5 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • 10-Minute Pembro/Nivo Infusions – Practice Changing Study?

      Started by: Louis Doherty in: General
      Discussion forum for members to discuss anything to do with oncology pharmacy

    • 1
    • 1
    • 7 months, 1 week ago

      Louis Doherty

    • Ipilimumab + nivolumab – severe reaction to both, what to do?

      Started by: Emma Foreman-Davies in: General
      Discussion forum for members to discuss anything to do with oncology pharmacy

    • 3
    • 3
    • 2 years ago

      Jennifer Laskey

    • blood validity period for immune checkpoint inhibitors

      Started by: Ibrahim Al-Modaris in: General
      Discussion forum for members to discuss anything to do with oncology pharmacy

    • 4
    • 5
    • 2 years, 9 months ago

      Caroline Clapham

    • Tocilizumab and infliximab for immune-related adverse events commissioning

      Started by: Chuck Lam in: General
      Discussion forum for members to discuss anything to do with oncology pharmacy

    • 1
    • 1
    • 4 years, 11 months ago

      Chuck Lam

    • Live vaccines and immunotherapy

      Started by: Mari Ifan in: General
      Discussion forum for members to discuss anything to do with oncology pharmacy

    • 2
    • 2
    • 6 years, 4 months ago

      Lisa Dobson

  •  

Viewing 5 topics - 1 through 5 (of 5 total)
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.